Jonathan C Trent Selected Research

Jonathan C Trent Research Topics

Disease

60	Neoplasms (Cancer) 11/2023 - 10/2002
38	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021 - 12/2003
26	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 10/2002
5	Neoplasm Metastasis (Metastasis) 11/2023 - 02/2005
5	Chondrosarcoma 01/2022 - 01/2015
4	Aggressive Fibromatosis (Desmoid) 01/2023 - 10/2016
3	Synovial Sarcoma (Synovioma) 05/2022 - 02/2005
3	Leiomyosarcoma 01/2022 - 11/2010
3	Hemangiosarcoma (Angiosarcoma) 09/2021 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 05/2015 - 03/2007
3	Edema (Dropsy) 01/2012 - 01/2010
3	Cardiotoxicity 02/2011 - 07/2003
2	Liposarcoma 11/2023 - 05/2015
2	COVID-19 09/2022 - 01/2021
2	Disease Progression 09/2021 - 01/2007
2	Angiosarcoma of the breast 07/2021 - 01/2019
2	Leukopenia 01/2021 - 07/2012
2	Fatigue 01/2019 - 02/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015 - 11/2009
2	Rhabdomyosarcoma 06/2015 - 11/2007
2	Ewing Sarcoma (Sarcoma, Ewing) 05/2015 - 01/2011
2	Solitary Fibrous Tumors 05/2013 - 11/2011
2	Breast Neoplasms (Breast Cancer) 07/2012 - 07/2003
1	Leiomyomatosis 01/2022
1	Wounds and Injuries (Trauma) 10/2021
1	Microsatellite Instability 09/2021
1	Pathologic Complete Response 07/2021
1	Carcinogenesis 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Cholangiocarcinoma 01/2019
1	Alveolar Soft Part Sarcoma 01/2019

Drug/Important Bio-Agent (IBA)

32	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 09/2004
9	Tyrosine Kinase InhibitorsIBA 11/2019 - 01/2005
7	Phosphotransferases (Kinase)IBA 09/2021 - 09/2004
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2005
6	EnzymesIBA 01/2020 - 07/2012
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2007
5	Sunitinib (Sutent)FDA Link 09/2021 - 04/2010
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 01/2015
5	pazopanib FDA Link 01/2019 - 07/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2002
3	Circulating Tumor DNAIBA 11/2020 - 01/2018
3	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2019
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019 - 02/2008
3	Ifosfamide FDA LinkGeneric 01/2019 - 12/2003
3	Small Interfering RNA (siRNA)IBA 01/2011 - 03/2007
2	Estrogen ReceptorsIBA 01/2022 - 07/2012
2	ivosidenibIBA 01/2020 - 01/2019
2	alpha-hydroxyglutarateIBA 01/2020 - 01/2015
2	TrabectedinIBA 01/2019 - 12/2012
2	Gemcitabine FDA Link 01/2019 - 01/2019
2	Docetaxel (Taxotere)FDA Link 01/2019 - 07/2003
2	Axitinib (AG 013736)IBA 01/2019 - 01/2019
2	pembrolizumabIBA 01/2019 - 01/2019
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2017 - 07/2016
2	Temozolomide (Temodar)FDA LinkGeneric 11/2011 - 12/2003
2	Platelet-Derived Growth FactorIBA 07/2010 - 07/2008
2	Insulin-Like PeptidesIBA 11/2009 - 10/2006
2	Dasatinib (BMS 354825)FDA Link 08/2009 - 03/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2008 - 07/2003
2	tyrosine receptor (receptor, tyrosine)IBA 11/2007 - 02/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2003 - 10/2002
1	PlacebosIBA 11/2023
1	Discoidin Domain Receptor 1IBA 11/2023
1	lissamine rhodamine B (sulforhodamine B)IBA 01/2023
1	ChromatinIBA 01/2023
1	RNA Polymerase II (RNA Polymerase B)IBA 05/2022
1	Cytotoxins (Cytolysins)IBA 05/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2022
1	CrizotinibIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Vinca AlkaloidsIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 09/2021
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	NitrogenIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	AlbuminsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	infigratinibIBA 01/2021
1	IntegrinsIBA 01/2020
1	DioxygenasesIBA 01/2020
1	isocitric acid (isocitrate)IBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	NivolumabIBA 01/2019

Therapy/Procedure

48	Therapeutics 11/2023 - 07/2003
14	Drug Therapy (Chemotherapy) 01/2022 - 11/2003
7	Radiotherapy 09/2021 - 11/2003
5	Immunotherapy 09/2021 - 07/2012
3	Neoadjuvant Therapy 07/2021 - 03/2010
3	Adjuvant Chemotherapy 01/2019 - 11/2003
2	Precision Medicine 11/2019 - 01/2018
1	Breast Implants (Breast Implant) 10/2021
1	Combined Modality Therapy 07/2021
1	Genomic Medicine 11/2019